Skip to Content

Hero Technologies Inc Ordinary Shares HENC

Morningstar Rating
$0.00 0.00 (6.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HENC is trading at a 57% discount.
Price
$0.01
Fair Value
$1.73
Uncertainty
Extreme
1-Star Price
$6.65
5-Star Price
$1.72
Economic Moat
Ztmz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HENC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.000.00
52-Week Range
$0.000.02
Bid/Ask
$0.00 / $0.00
Market Cap
$2.60 Mil
Volume/Avg
106,465 / 64,595

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Hero Technologies Inc is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations, and dispensaries. It focuses on two principal segments of the cannabis industry, cultivation, and the dispensary business model, including combinations.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
HENC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
HENC
Quick Ratio
1.32
Current Ratio
1.41
Interest Coverage
−41.13
Quick Ratio
HENC

Profitability

Metric
HENC
Return on Assets (Normalized)
−61.09%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−69.84%
Return on Assets
HENC
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ALdxchgdsqZwfm$70.0 Bil
MKKGY
Merck KGaA ADRTtlqdtxkTfvgvq$67.6 Bil
HLN
Haleon PLC ADRMnskdjjdVsd$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRHvhrvwrHtk$14.3 Bil
VTRS
Viatris IncFvkzkdxqDzys$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRBgbsptvvJxzn$11.9 Bil
CTLT
Catalent IncPvbhnydGwnrmdm$10.0 Bil
PRGO
Perrigo Co PLCYzcwjrhmVmj$4.1 Bil
CURLF
Curaleaf Holdings IncCstvbqxlRcph$3.6 Bil
PBH
Prestige Consumer Healthcare IncPzmskhtZjjrxc$3.4 Bil

Sponsor Center